CIK: 0001056807 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $2,799,144 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $932,261 | 33.3% | $6.29 | +548.1% | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,502,710 | $240,138 | 8.6% | $32.29 | +6.6% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 4,982,384 | $183,302 | 6.5% | $31.23 | +23.0% | COM | 76155X100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,211,041 | $177,474 | 6.3% | $29.18 | +64.5% | COM | 74366E102 |
| AXSM | AXSOME THERAPEUTICS INC | 1,690,221 | $176,442 | 6.3% | $85.51 | +23.8% | COM | 05464T104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,761,333 | $140,524 | 5.0% | $27.38 | +62.6% | COM | 604749101 |
| GHRS | GH RESEARCH PLC | 8,827,712 | $107,610 | 3.8% | $18.98 | -42.2% | ORDINARY SHARES | G3855L106 |
| IONS | IONIS PHARMACEUTICALS INC | 1,913,385 | $75,598 | 2.7% | $32.75 | -0.1% | COM | 462222100 |
| XOMA | XOMA ROYALTY CORPORATION | 2,590,303 | $65,276 | 2.3% | $15.57 | +53.8% | COM NEW | 98419J206 |
| ZYME | ZYMEWORKS INC | 4,308,935 | $54,077 | 1.9% | $7.03 | +69.5% | COM | 98985Y108 |
| SEPN | SEPTERNA INC | 4,396,124 | $46,467 | 1.7% | $18.24 | -54.8% | COM | 81734D104 |
| CELC | CELCUITY INC | 3,466,000 | $46,271 | 1.7% | $16.73 | -34.9% | COM | 15102K100 |
| KURA | KURA ONCOLOGY INC | 7,754,129 | $44,741 | 1.6% | $9.83 | -37.7% | COM | 50127T109 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $43,303 | 1.5% | $20.31 | -60.4% | COM | 230031106 |
| ACIU | AC IMMUNE SA | 19,822,436 | $40,240 | 1.4% | $4.49 | -61.3% | SHS | H00263105 |
| — | CIDARA THERAPEUTICS INC | 786,392 | $38,305 | 1.4% | $16.88 | — | COM NEW | 171757206 |
| TYRA | TYRA BIOSCIENCES INC | 3,944,194 | $37,746 | 1.3% | $16.23 | -41.4% | COM | 90240B106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,771,417 | $36,739 | 1.3% | $34.21 | — | SPONSORED ADS | 86366E106 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,024,288 | $32,142 | 1.1% | $31.38 | — | ADS | 45258D105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 5,660,132 | $25,527 | 0.9% | $6.80 | -34.4% | COM | 61225M102 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $24,919 | 0.9% | $5.96 | -29.8% | COM | 344174107 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $22,561 | 0.8% | $37.66 | -88.2% | COM | 68062P106 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,387,863 | $22,400 | 0.8% | $21.15 | 0.0% | COM | G2545C104 |
| XNCR | XENCOR INC | 2,740,141 | $21,538 | 0.8% | $20.61 | -56.5% | COM | 98401F105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,629,289 | $17,175 | 0.6% | $13.79 | -74.5% | COM | 35104E100 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $17,055 | 0.6% | $4.95 | -39.4% | COM | 28617K101 |
| ANNX | ANNEXON INC | 7,000,000 | $16,800 | 0.6% | $2.47 | -19.0% | COM | 03589W102 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 696,555 | $15,700 | 0.6% | $15.71 | +49.4% | COM | 697947109 |
| — | ESSA PHARMA INC | 8,748,629 | $14,873 | 0.5% | $3.65 | — | COM NEW | 29668H708 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $14,364 | 0.5% | $19.56 | — | COM | 760273102 |
| VSTM | VERASTEM INC | 3,404,425 | $14,128 | 0.5% | $6.32 | -0.8% | COM NEW | 92337C203 |
| RAPT | RAPT THERAPEUTICS INC | 1,154,692 | $9,238 | 0.3% | $7.63 | 0.0% | COM NEW | 75382E208 |
| FBRX | FORTE BIOSCIENCES INC | 588,344 | $7,607 | 0.3% | $11.57 | -25.6% | COM NEW | 34962G208 |
| TCRX | TSCAN THERAPEUTICS INC | 5,226,074 | $7,578 | 0.3% | $2.41 | -40.1% | COM | 89854M101 |
| — | IKENA ONCOLOGY INC | 4,006,564 | $5,369 | 0.2% | $12.00 | — | COM | 45175G108 |
| IMUX | IMMUNIC INC | 7,652,972 | $5,338 | 0.2% | $1.30 | -29.3% | COM | 4525EP101 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5,186 | 0.2% | $9.66 | — | ADS | 60853G106 |
| AVTX | AVALO THERAPEUTICS INC | 1,028,049 | $5,130 | 0.2% | $10.33 | -54.8% | COM NEW | 05338F306 |
| IVA | INVENTIVA SA | 686,040 | $2,140 | 0.1% | $13.70 | — | ADS | 46124U107 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $1,983 | 0.1% | $3.62 | +59.6% | COM NEW | 88032L605 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $1,606 | 0.1% | $5.51 | -70.0% | COM NEW | 78397T202 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $1,271 | 0.0% | $4.24 | -92.9% | COM | 690469101 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $586 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $417 | 0.0% | $5.07 | — | COM NEW | H57830137 |